| Return to Contents in this Issue |
Practitioner's Corner |
|
Toxic Epidermal Necrolysis Successfully Treated With Infliximab |
|
LC Zárate-Correa,1 DC Carrillo-Gómez,1 AF Ramírez-Escobar,2 C Serrano-Reyes1,3 |
|
1 Department of Interrnal
Medicine, Fundación Valle del Lili, Cali, Colombia |
|
J Investig Allergol Clin Immunol 2013; Vol. 23(1): 50-73 |
|
|
